Wedbush upgraded Voyager Therapeutics (VYGR) to Outperform from Neutral with a price target of $11, up from $7, after assuming coverage of the ...
Tesla’s Elon Musk and his close relationship with President-elect Trump are already having a huge impact on the EV maker, ...
News of an investigation by the Federal Trade Commission into Microsoft (NASDAQ:MSFT) is "not a worry" with Chairwoman Lina ...
Gary Black of The Future Fund LLC confirmed that Tesla's Cybercab won't launch until 2026, dismissing early rollout rumors, ...
Wedbush notes that in the past two weeks Kioxia filed for an IPO and SanDisk released its 10-12B, telling investors that data from these ...
We recently published a list of 15 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...
The EV maker’s stock gained 3.7% on Friday, leaving the shares ahead nearly 40% for the year and giving it a market value of ...
Wedbush has assumed coverage of Voyager Therapeutics (NASDAQ:VYGR) with an outperform rating, highlighting the company’s ...
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.BMDkfsfZ.js ...
Microsoft stock was lagging behind its tech peers on Friday as investors reacted to news the company is facing a broad ...
In an interview with CNBC on November 25, Dan Ives, Global Head of Technology Research at Wedbush Securities said that he ...
Apple Inc.’s skeptics and bears have missed the last more than $1 trillion upward move in the stock by overlooking three key dynamics behind the story, Wedbush analysts said Friday. Apple has an ...